ITC 2022 is no longer on the App Store. It had too few ratings to say what users thought.
ITC 2022 is made and published by Prime Solutions LTD OOD. AppBrain is an independent app data site and isn't affiliated with Prime Solutions LTD OOD. The app name, icon, screenshots and description belong to Prime Solutions LTD OOD and are shown as published on the App Store.
About ITC 2022
ITC 2022 was a medical app developed by Prime Solutions LTD OOD. It was removed from the App Store Mar 16, 2025.
User Ratings
ITC 2022 was rated 4.00 out of 5 stars, based on one rating ratings.
App Information
ITC 2022 was free. The app size was 51.92 MB. The last available version was 1.1.3. The last update was on February 15, 2022.
Technical Requirements
The app had a content rating of Everyone. The app had been available on the App Store since February 2020.
More data about ITC 2022
| Price | Free |
| Rating | 4.00 based on a single rating |
| Version | 1.1.3 |
| App size | 51.9 MB |
| Suitable for | Everyone |
Similar apps
Screenshots
More from Prime Solutions LTD OOD
Changelog of ITC 2022
No changelog data
Developer information for Prime Solutions LTD OOD
Address:
Comments on ITC 2022 for iOS
We don't have enough comments to show example comments. Please check back later.
Technologies used by ITC 2022
Frequently asked questions about ITC 2022
Is ITC 2022 free?
Yes. ITC 2022 was free on the App Store.
Is ITC 2022 still available?
No. ITC 2022 was removed from the App Store. We last saw it there Mar 16, 2025.
How large is ITC 2022?
ITC 2022 is 51.92 MB.
Is ITC 2022 suitable for children?
App Store rates the content of ITC 2022 as suitable for everyone.
How do people rate ITC 2022?
ITC 2022 had one rating of 4.00 stars on the App Store.
Who made ITC 2022?
ITC 2022 was developed by Prime Solutions LTD OOD. It was listed in the medical category on the App Store.
What are the best alternatives to ITC 2022?
People looking at ITC 2022 also look at these medical apps: Scrips Provider, Emirates Hospitals, HiRO Doctor, Medacta More, Flabuless Inc.